Reprinted from Liberty Counsel
FDA Approves Pfizer Booster COVID Shot for Children
WASHINGTON, D.C.—Today, the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) and authorized a booster dose of the Pfizer-BioNTech COVID-19 shot for children 5 through 11 years of age. The booster shot is 10 micrograms, which is the same dosage for this age group in their primary series and a third of that given to people aged 12 and older.
The decision will now go to the Centers for Disease Control and Prevention (CDC) for approval.
On April 28, 2022, Moderna submitted a request to the FDA for EUA for its two-dose COVID-19 injection for children ages six months to under six years old….